Last, using a classification system being developed by the Kalari group (CALAR), the vast majority of all tumors were classified as basal (bTNBC) (80.9%), and no significant differences were detected for the distribution of ERβ+ versus ERβ− cancers (p = 0.596) (Table 2). This evidence concerns the gene ESR2 and cancer.